FEDERAL COURT OF AUSTRALIA
Stambe v Minister for Health (No 2) [2019] FCA 479
Keep reading for free
Create a free CaseChat account to read Stambe v Minister for Health (No 2) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2019] FCA 479
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the court were whether the Minister’s decision was affected by legal error and what form the final orders should take. The court had to consider whether the Minister had exercised the discretion conferred on them by section 90A(2) of the National Health Act 1953 (Cth) lawfully and whether there was a duty on the Minister to grant the approval under section 90B(5) of the same Act. Additionally, the court needed to determine the appropriate timing for setting aside the decision and remitting the matter to the Minister, considering the potential financial and operational impacts on the second respondent.
The court found that the Minister’s decision was indeed affected by legal error and that the Minister had failed to consider all relevant factors. The court concluded that the appropriate remedy was to remit the matter to the Minister for reconsideration, allowing the second respondent to provide further information or documents. Regarding the timing, the court decided that both the setting aside order and the remitter order should take effect simultaneously, with the remitter order being made immediately after the setting aside order. This approach balanced the need for the Minister to reconsider the decision with the potential economic impact on the second respondent.
The final orders of the court set aside the Minister’s decision with effect from 9 am on 11 June 2019 and remitted the matter to the Minister for further consideration according to law. The court also ordered that the Minister invite the applicant to provide comments, information, or documents relevant to the request. Furthermore, the court ordered that the Minister pay the applicant’s costs, and the second respondent pay the applicant’s costs.
Orders
Orders of the court
1. Pursuant to s 16(1)(a) of the Administrative Decisions (Judicial Review) Act 1977 (Cth), with effect from 9 am on 11 June 2019, set aside the decision of the first respondent made on 1 November 2017 approving the supply of pharmaceutical benefits by the second respondent from premises located at 58 and 60 Pinewood Drive and 399, 401 and 403 Blackburn Road, Mount Waverley in the State of Victoria.
2. Pursuant to s 16(1)(b) of the Administrative Decisions (Judicial Review) Act 1977 (Cth), with effect from 11 June 2019 and immediately after the order in paragraph 1 coming into force, the matter of the second respondent’s application dated 7 June 2017 for Ministerial approval under s 90A(2) of the National Health Act 1953 (Cth) to supply pharmaceutical benefits be remitted to the first respondent for further consideration according to law.
3. After the remitter pursuant to paragraph 2 and before deciding whether to substitute the Secretary’s decision not to grant approval to the second respondent to supply pharmaceutical benefits, the first respondent is to advise the applicant of that request conformably with s 90D(1)(b) of the National Health Act 1953 (Cth), and invite him to provide comments on, or information or documents relevant to, the request within such period as the first respondent may specify.
4. The first respondent pay the applicant’s costs fixed in the amount of $35,093.33.
5. The second respondent pay the applicant’s costs fixed in the amount of $28,906.67.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Therefore, my conclusion is that the orders setting aside the Minister’s decision and remitting the matter to the Minister for further consideration should both be made in the same order, and take effect at the same time; or, technically, one immediately after the other.Discretionary considerations as to the timing of the Court’s orders Mr Yab’s affidavit evidence deposes to the considerable costs expended on establishing the pharmacy, in terms of fit-out costs, and then the considerable time it took for the pharmacy to break even after commencing trading. His evidence also goes into some detail about the way the pharmacy’s services have been accessed, such as the number of scripts filled by the pharmacy between particular hours and the number of customers who have been accessing the pharmacy outside the hours of 9am to 9pm. The affidavit evidence also sets out what are contended to be the consequences of the pharmacy having to close, referring to matters such as sales of PBS medicines in the area and access of customers to pharmaceutical benefits outside normal business hours, and the likely significant financial impact on the second respondent of having to close the pharmacy. I accept that if the Minister’s approval is set aside with immediate effect on the making of the Court’s orders, the second respondent, through its principal, Mr Yab, will not be authorised to dispense the “drugs” and “medicinal preparations” which fall within the definition of “pharmaceutical benefits” in s 84 of the National Health Act from its premises, and claim a subsidy from the Commonwealth in doing so. The second respondent would not be prevented from dispensing PBS medicines, but would be prevented from claiming the subsidy, thus making them (I infer) more expensive for members of the public, as Jagot J explained in Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2018] FCA 1556; 136 IPR 8 at [64]:A pharmacist may dispense products privately, that is, not through the PBS, even where the products are PBS listed. Prescription products which are not listed on the PBS are dispensed privately. If a pharmacist dispenses a product privately the patient bears the full purchase price of the product as no Commonwealth subsidy is paid under the PBS. I accept that a significant proportion of the pharmacy’s revenue is obtained by the sale of PBS medicines, and therefore, as a consequence of the Minister’s approval being set aside, the second respondent may need to consider whether to continue operating the pharmacy, and if Mr Yab decides to close it, there may be significant economic loss. Although this evidence was untested, there is no objective reason to doubt it has substance. The applicant did not submit otherwise. I also accept Mr Yab’s evidence suggests there may be some loss of services in the area to the general public if the pharmacy closes, although I find the significance of the loss may be difficult to quantify because it is dependent on predictions of human behaviour. People may adapt to changed circumstances in a number of ways. I do not accept the situation would necessarily be as dire as Mr Yab’s evidence, and that of Dr Cunneen, paint it.